Intravesical bacillus calmette-guérin versus mitomycin c for ta and t1 bladder cancer: Abridged summary of the cochrane review

Schmidt S, Kunath F, Coles B, Draeger DL, Krabbe LM, Dersch R, Kilian S, Jensen K, Dahm P, Meerpohl JJ (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Korean Journal of Urology Korean Urological Association

Book Volume: 61

Pages Range: 349-354

Journal Issue: 4

DOI: 10.4111/icu.2020.61.4.349

Authors with CRIS profile

Frank Kunath Urologische Klinik

Involved external institutions

Cardiff University GB United Kingdom (GB) Ruprecht-Karls-Universität Heidelberg DE Germany (DE) Deutsche Gesellschaft für Urologie DE Germany (DE) Va Midwest Health Care Network US United States (USA) (US) Albert-Ludwigs-Universität Freiburg DE Germany (DE)

How to cite

APA:

Schmidt, S., Kunath, F., Coles, B., Draeger, D.L., Krabbe, L.M., Dersch, R.,... Meerpohl, J.J. (2020). Intravesical bacillus calmette-guérin versus mitomycin c for ta and t1 bladder cancer: Abridged summary of the cochrane review. Korean Journal of Urology, 61(4), 349-354. https://doi.org/10.4111/icu.2020.61.4.349

MLA:

Schmidt, Stefanie, et al. "Intravesical bacillus calmette-guérin versus mitomycin c for ta and t1 bladder cancer: Abridged summary of the cochrane review." Korean Journal of Urology 61.4 (2020): 349-354.

BibTeX: Download